JCR Pharmaceuticals Co., Ltd. (OTCMKTS:JCRRF – Get Free Report) shares shot up 11.8% during mid-day trading on Wednesday . The stock traded as high as $4.75 and last traded at $4.75. 800 shares were traded during trading, an increase of 82% from the average session volume of 440 shares. The stock had previously closed at $4.25.
JCR Pharmaceuticals Trading Up 11.8%
The business’s fifty day simple moving average is $4.51 and its 200-day simple moving average is $4.48.
About JCR Pharmaceuticals
JCR Pharmaceuticals Co, Ltd. is a Japan-based biotechnology company specializing in the development, production and commercialization of plasma-derived products and regenerative medicine solutions. The company focuses on manufacturing high-purity plasma proteins, including human serum albumin, immunoglobulins and coagulation factors, to support a range of therapeutic applications in hematology, immunology and critical care settings.
In its plasma-derived business, JCR leverages state-of-the-art fractionation and purification processes to supply products such as intravenous immunoglobulin and albumin formulations.
Further Reading
- Five stocks we like better than JCR Pharmaceuticals
- If You Keep Cash In A U.S. Bank Account… Read This NOW
- Do not delete, read immediately
- How a Family Trust May Be Able To Help Preserve Your Wealth
- Trump Devises the Death of the IRS ☠️
- Buy this $2 Gold Stock Before January 1, 2026
Receive News & Ratings for JCR Pharmaceuticals Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for JCR Pharmaceuticals and related companies with MarketBeat.com's FREE daily email newsletter.
